Evidence map›Paper›PMID 32615919›Full record

ArticleBMC bioinformatics2020

Accounting for grouped predictor variables or pathways in high-dimensional penalized Cox regression models.

Shaima Belhechmi, Riccardo De Bin, Federico Rotolo, Stefan Michiels

Abstract read
In one paragraph

Article in BMC bioinformatics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. A CLRN3-Based CD8Biomolecules · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shaima BelhechmiUniversité Paris-Saclay, Univ. Paris-Sud, UVSQ, CESP, INSERM U1018 Oncostat, Villejuif, F-94805, France.
Riccardo De BinDepartment of Mathematics, University of Oslo, Oslo, Norway.
Federico RotoloBiostatistics and Data Management Unit, Innate Pharma, Marseille, France.
Stefan MichielsUniversité Paris-Saclay, Univ. Paris-Sud, UVSQ, CESP, INSERM U1018 Oncostat, Villejuif, F-94805, France. Stefan.MICHIELS@gustaveroussy.fr.ORCID http://orcid.org/0000-0002-6963-2968

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe standard lasso penalty and its extensions are commonly used to develop a regularized regression model while selecting candidate predictor variables on a time-to-event outcome in high-dimensional data. However, these selection methods focus on a homogeneous set of variables and do not take into account the case of predictors belonging to functional groups; typically, genomic data can be grouped according to biological pathways or to different types of collected data. Another challenge is that the standard lasso penalisation is known to have a high false discovery rate.

resultsWe evaluated different penalizations in a Cox model to select grouped variables in order to further penalize variables that, in addition to having a low effect, belong to a group with a low overall effect; and to favor the selection of variables that, in addition to having a large effect, belong to a group with a large overall effect. We considered the case of prespecified and disjoint groups and proposed diverse weights for the adaptive lasso method. In particular we proposed the product Max Single Wald by Single Wald weighting (MSW*SW) which takes into account the information of the group to which it belongs and of this biomarker. Through simulations, we compared the selection and prediction ability of our approach with the standard lasso, the composite Minimax Concave Penalty (cMCP), the group exponential lasso (gel), the Integrative L1-Penalized Regression with Penalty Factors (IPF-Lasso), and the Sparse Group Lasso (SGL) methods. In addition, we illustrated the methods using gene expression data of 614 breast cancer patients.

conclusionsThe adaptive lasso with the MSW*SW weighting method incorporates both the information in the grouping structure and the individual variable. It outperformed the competitors by reducing the false discovery rate without severely increasing the false negative rate.

Indexed as

Biomarkers, TumorBreast NeoplasmsComputational BiologyComputer SimulationFemaleGene Expression Regulation, NeoplasticHumansProportional Hazards ModelsBiomarkers, TumorBiomarker selectionCox modelHigh-dimensionalLasso penaltyPathwaysPrecision medicineStratified medicine

Identifiers

PMID32615919
PMCPMC7331150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.